Ashish Thakur

Company: AstraZeneca

Job title: Director, DMPK, Oncology

Bio:

Seminars:

Roundtable Discussion: How Stable Should an ADC Be? Aiding with PK Predictability & Risk Benefit Ratio 12:00 pm

Discussing the balance between ADC stability and release kinetics to optimize pharmacokinetics and therapeutic effect Exploring how stability influences safety risks and the overall benefit-risk profile in clinical settings Sharing perspectives on designing stability profiles that support predictable PK and maximize patient benefitRead more

day: Conference Day Two

Investigating the Effects on Modelling & Dosing When Expanding into ADC Combinations 9:30 am - 12:30 pm

Join this workshop to explore how next generation dosing strategies can unlock the full potential of ADC combination therapies. There is no silver bullet for treatment, and combinations are widely considered the next step in oncology treatment, so in this workshop you’ll dive into the latest thinking, tools, and translational tactics that are reshaping combination…Read more

day: Pre-Conference Workshop Day